Clinical trial
Risperidone for the Treatment of Huntington's Disease Chorea
NCT04201834 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risperidone for the Treatment of Huntington's Disease Chorea
- Lead sponsor
- University of Rochester
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 13, 2020
- Completion date
- December 30, 2023
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.